rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
49
|
pubmed:dateCreated |
2000-12-20
|
pubmed:abstractText |
To estimate the cost-effectiveness of antenatal screening for Chlamydia trachomatis.
|
pubmed:language |
dut
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0028-2162
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
144
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2350-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11129971-Adolescent,
pubmed-meshheading:11129971-Adult,
pubmed-meshheading:11129971-Chlamydia Infections,
pubmed-meshheading:11129971-Chlamydia trachomatis,
pubmed-meshheading:11129971-Cost-Benefit Analysis,
pubmed-meshheading:11129971-Female,
pubmed-meshheading:11129971-Humans,
pubmed-meshheading:11129971-Mass Screening,
pubmed-meshheading:11129971-Netherlands,
pubmed-meshheading:11129971-Pregnancy,
pubmed-meshheading:11129971-Pregnancy Complications, Infectious,
pubmed-meshheading:11129971-Prenatal Care
|
pubmed:year |
2000
|
pubmed:articleTitle |
[Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
|
pubmed:affiliation |
Groningen University Institute for Drug Exploration/Groningen Research Institute of Pharmacy, Antonius Deusinglaan 1, 9713 AV Groningen.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|